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JACOBSON, HOMER (Brooklyn College of the City University of New York, 
Brooklyn, N.Y.), AND LESLIE S. JACOBSON. Virustat, a device for continuous produc- 
tion of viruses. Appl. Microbiol. 14:94&952. 1966.-Methods for continuous 
production of viruses, and operation of the virustat, an apparatus in which such 
production was accomplished, were studied. Continuous production requires a 
separate continuous host growth chamber, such as the chemostat, and a multiunit 
virus growth chamber into which the virus-inoculated host cells are led. Successful 
continuous output of MS-2 and 4x174 viruses, the latter in lysates, over periods 
of several days and at  titers approximating those of batch lysates, was observed. 
Design problems include chamber sizes and flow rates, growth of resistant mutants 
within both virus and host growth chambers, clogging by lysis debris, and the phe- 
nomenon of self-inoculation. The latter represents virus growth in the first section 
of the chamber in excess of the washout rate, leading to lack of need for virus in- 
oculation after an initial period. Use of the virustat for production and research 
purposes will require some attention to the formation of resistant bacterial colonies 
at pockets and surface sites of limited washout. With the virustat as a continuous 
virus production device, continuous purification methods are desirable. Research 
use of the virustat in continuous mutagenic population studies would require sup- 
pression of self-inoculation by use of many sections in the chamber, and improved 
servo control of host populations at low concentrations. 
This paper presents methods for continuous 
protuction of viruses, particularly bacterio- 
phages, and the first results with the virustat, an 
apparatus for accomplishing this end. Virus cul- 
ture methods published prior to this report have 
been batch methods, in which a host organism or 
tissue, or a batch of host cells (if they are cultura- 
ble in single-cell suspension), is treated with a 
small inoculum of virus particles, and a larger 
quantity of virus is harvested after some required 
time in a batch of product. Using appropriate 
hosts and media, we have constructed and oper- 
ated a relatively simple device giving continuous 
output of bacterial viruses 4x174 and MS-2. 
Suitable for production of any virus whose host 
cells can be cultured in infectible suspension, we 
have named it "virustat" in analogy with the 
bacteria-producing chemostat of Szilard and 
Novick (10). Over run periods of 1 to 6 days, the 
apparatus continuously produced virus lysates at  
1 Present address: Department of Biology, Long 
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flow rates of 20 to 170 ml/hr, and at  titers ranging 
nearly to those given by optimal batch cultures. 
General design considerations. Continuous pro- 
duction of virus requires (i) a continuous supply 
of host cells from a host cell growth tube (the 
method is inapplicable to cultures which require 
host tissues or whole multicellular organisms), 
(ii) a virus growth chamber in which host cells 
and virus inoculum are continuously mixed and 
kept together long enough to produce a continu- 
ous supply of new virus, and (iii) a continuous 
inoculum, either from an available virus supply 
or by return of a fraction of the production (under 
certain conditions given below, this may be 
omitted). Bacterial viruses are especially con- 
venient for continuous culture, as the host cells 
are easily grown in continuous pure culture by 
several methods (3, 7, 10). 
Plant and animal viruses present greater prob- 
lems, in that they require single-cell or suspended 
cell-clump cultures; however, with methods under 
current study (2, 6), these problems should be- 
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come amenable t o  the methods described here. 
The simple method of Monod (7), comprising 
continuous medium flow and simultaneous with- 
drawal of the well-mixed cell culture a t  the same 
rate, produces a continuous supply of host cells. 
The equilibrium concentration reached depenc's 
upon the flow rate. As medium flow rate increases 
from zero up  t o  a critical rate, the concentration 
decreases from near-saturation t o  the concentra- 
tion a t  which the exponential growth rate is rnaxi- 
mall i.e., the shoulder of the growth curve. Above 
the critical flow rate, the medium washes out the 
bacteria or other cells faster than they reproduce, 
and they disappear, except for surface growth and 
growth in unmixed pockets. Virus cultures with 
bacteriophage are generally carried out a t  concen- 
trations of host bacteria near the shoulder of 
growth curves for maximal virus production, and 
the virustat was designed t o  operate in this range. 
Due t o  the need for turbulence for aeration and 
suspension of particles, a simple tube-type virus 
growth chamber with host and inoculum coming 
in at  one end and production coming out a t  the 
other will not work well. Nor will a single well- 
mixed and aerated chamber, in which new cells 
and virus are being continuously added with con- 
tinuous product removal. Such a chamber mixes 
the entire contents, and would have a n  excessively 
wide distribution of "ages" of infected cells; the 
production would be heavily contaminated with 
both uninfected and unlysed cells, and would also 
retain considerable virus (titers of which are fre- 
quently labile) in a warm and heavily absorbing 
culture long after it was produced. The method 
used practically must provide aeration of the 
stream of infected material along a path which 
does not excessively mix cells of different ages. 
The continuous supply of bacteria, together 
with enough virus particles t o  inoculate them, 
must be held together in some kind of chamber 
long enough for the cells t o  lyse and then run off 
as  production. The virustat uses a virus growth 
chamber containing many Cells in series, with 
separate volumes for individual mixing and aera- 
tion. (We capitalize "Cell" when referring t o  the 
units of the virus growth chamber, so as  not t o  
confuse the term with the biological one.) Mixing 
is rapid in each Cell, aeration is present in each, 
and the infected cells pass through each Cell in 
turn. This system causes a peaking of the distribu- 
tion of the "ages" of the cells in the production, 
as  described in detail below, the distribution be- 
coming more peaked a s  the number of Cells is 
increased. Sufficient Cells allow uniformity of 
ages t o  approach that attained in a batch of virus 
growth. 
Cultures of two bacteriophages, 4x174 and MS-2, 
and their Escherichia coli hosts, strains C and K-12 
3000 Hfr, respectively, kindly supplied by R. L. 
Sinsheimer's laborator), were used in the experiments. 
Batch cultures of 4x174 gave us 45-min lysates with 
titers of up to 4 X 10ll/ml; cultures of MS-2 yielded 
up to 4 X 10'2/ml, but required 3 to 5 hr f o ~  often 
somewhat cloudy lysates. Media used for growth were 
Fraser's glycerol-Casamino Acids and Zinder's tryp- 
tone-yeast extract, respectively, as described by 
Sinsheimer (9) and Davis and Sinsheimer (1). Plating 
methods used were also as there described. All growth 
was carried out in a room held at 37 f 0.3 C. Medium, 
held at room temperature in an adjoining room, was 
pumped into the room and into the bacterial growth 
tube at the desired rate with a Bowman (peristaltic) 
infusion pump (Process and Instruments, Brooklyn, 
N. Y.). When the tube had filled to the desired level, it 
was inoculated with a few per cent by volume of fresh 
overnight culture of host cells, aerated, and allowed to 
reach upper log phase (2 X 108 to 5 X 108/ml). Inflow 
of medium, usually interrupted during growth of host 
cells, was then resumed; inflow was balanced by 
gravity-controlled outflow into the virus growth 
chamber so as to preserve the level of volume in the 
bacterial growth tube. With both hosts and the media 
used, setting the medium input (and cell culture out- 
put) flow rates at from 0.5 to 0.8/hr times the volume 
in the bacterial growth tube (i.e., 2 to 1.25 hr average 
turnover time) resulted in maintaining the bacterial 
count in the 2 X 108 to 5 X lOa/ml region. In practice, 
since the desired flow rate was set first from considera- 
tion of desired average time in the virus growth 
chamber, this means choosing a volume of culture in 
the growth tube to give the proper steady-state at the 
selected flow rate. 
Virus inoculum, held in a refrigerator, was then 
pumped into the effluent stream of host bacteria before 
it entered the first Cell. Valve-type pumps proved un- 
satisfactory owing to debris clogging. The same 
,peristaltic pump used for the medium, with flow re- 
duced by the use of narrow-bore tubing, carried the 
virus inoculum into the stream with a flow rate set 
to give the approximate multiplicity of infection de- 
sired, at the existent bacterial and inoculum virus 
titers. Further movement of culture was accomplished 
by gravity flow through the Cells of the virus growth 
chamber in order, and thence back into the collecting 
vessel in the refrigerator. 
Figure 1 shows the arrangement of the entire ap- 
paratus schematically. The dotted boxes enclose the 
refrigerated area (RA) and the room temperature area 
(RTA). Shown in these areas are the medium reservoir 
bottle (MB), peristaltic pump (PP), inoculum reser- 
voir bottle (IB), and production reservoir bottle (PB). 
The remainder of the apparatus depicted, within the 
warm room, includes the bacterial growth tube (Y), 
backflow traps (B), blowover bottle (BB), air intake 
(AI) and output (AO) manifolds, three Cells (first 
and last are labeled 1 and 10, with a schematic hiatus 
after the second), and tees for host-cell inoculation (I) 
and for sampling (T). Arrows indicate path of air, 
and of medium (M), host cells (H), virus inoculum 
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FIG. 1. Schematic diagmm of virustat. 
FIG. 2. Virustar in operation during run 43. Symbols as in texr. 
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(V), and production output (0). The long dashed 
line indicates the gradual liquid level drop, somewhat 
exaggerated, driving the gravity flow from bacterial 
growth tube to production reservoir bottle inlet. 
Figures 2-5 show the actual apparatus under run 
conditions. Figure 2 shows a run with a ten-Cell cham- 
ber; note the striking change in culture turbidity from 
CeU 1 (right) to Cell 10 (left). It is labeled with sym- 
bols identical to those of Fig. 1. 
Figure 3 shows the overall setup during a run with 
a MCell chamber. The flask at the far left is a blow- 
over vessel connected to the air outlet to catch any 
foaming-over culture. Backflow traps, a necessary pre- 
caution to avoid contamination of medium and bat- 
terial growth tube, are visible in Fig. 2 and 3; the Fen- 
wal Thermoswitch controlling room temperature is 
likewise prominent. Figures 4 and 5 show the details 
of the virus growth chamber. The section comprising 
Cells 1 to 10 (seen right-to-left) is shown in Fig. 4; 
Cells 11 to 20 are shown in Fig. 5. Increased foaminess 
and some clearing is visible in Cells 11 to 20, although 
not as dramatically as in Fig. 2. The scale in Fig. 3-5 
can be estimated from the approximately 3cm-wide 
pinch clamps, and in Fig. 2 from the l k m  scale line. 
Normal volume complement of each Cell in the 
earlier runs (Fig. 2) was 10 ml; in the 20 and 25 Cell 
setups (Fig. 3-5), 5 to 6 ml. A 20-Cell chamber would 
have a holdup total of about 120 ml; therefore, a total 
average duration of 1 hr in the chamber from inocula- 
tion to collection would require a flow rate of 120 
ml/hr. Flow rates varied between 20 and 170 ml/hr, 
in experiments performed. Samples for bacterial and 
virus counts were taken, as required, &om the sam- 
pling tees and from the side arm in the bacterial 
growth tube; they were diluted in cold broth and 
titered within 12 hr. Resistant mutants were measured 
in viruscontaining production samples by direct 
normal plating of sequential dilutions, and in bac- 
terial growth tube samples containing no virus, by 
adding approximately lo7 phage particles from lysates 
filtered through a type HA membrane filter (Millipore 
Filter Corp., Bedford, Mass.) with each 0.1-ml sam- 
ple of bacterial dilution plated. 
RESULTS 
Production of host cells continuously a t  the 
desired concentration was found possible in pre- 
liminary runs, by use of Monod's method (7), 
and the hosts and media specified above. When 
small batches of the continuously produced cells 
were inoculated with virus, even after several days 
of running in a bacterial growth chamber, they 
were found to  give lysates. 
Results of the first set of 13 significant virustat 
runs are summarized in Table 1, which gives the 
number of Cells, culture flow rate, size of growth 
FIG. 3. Virustat in operation during run 67. Complete system at 37 C. 
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FIO. 4. Virustat in operation during run 97. First ten tubes of chamber. 
Fra. 5. Virustat in opemtion during run 97. Lart ten tubes of chamber. 
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TABLE 1 .  Summary of results o f  virustat run9 
tube culture, representative bacteria count in 
growth tube, and virus titer in first and last 
("production") Cells. Run duration and self- 
inoculation (below) is also recorded. 
Runs M1 and M2, made with MS-2 virus and 
host, showed no lysis along the growth chamber 
at the flow rates employed, even though the cul- 
ture spent 3 to 6 hr in it, a time long enough for 
lysis of batch cultures. Continuing the experi- 
ments in the absence of visible indications of 
lysis, phage titers revealed, nevertheless, a con- 
tinuous production in the 10ll/ml range over the 
entire duration of the runs (20 to 64 hr). Turning 
off the virus inoculum pump early in the first run 
led to no appreciable drop in output titer, verify- 
ing the self-inoculation concept treated in the dis- 
cussion. As E. coli 3000 has an exceptionally large 
fraction (order of 10-4) of MS-2-resistant bac- 
teria, presumably F species, even in freshly 
cloned cultures, and as these would be expected 
to increase with time in the virustat, lysis must 
have been hidden by the large population of re- 
sistant bacteria. 
The total production of MI,  about 2,000 ml at 
a titer of >10ll/ml, contained >2 X 1014 phage 
particles, compared to a maximal inoculum of 
20 ml containing <2 x 1012/ml, or a total of 
<4 x 1013 particles, a minimal phage increase of 
M1 
M2 
441 
62 
63 
45c 
46-80 
@7b 
~8~ 
@ 9 ~  
@ l o b  
@ l l b  
fivefold in the apparatus. For M2, the 400-ml pro- 
duction at >2 x 1OU/ml, compared with <10 ml 
of inoculum containing < 5 x 1010/ml, represents 
a minimum of 160-fold phage increase, leaving no 
doubt of actual phage production. Subsequent 
runs (below) gave similarly large increases over 
the rather variable inoculum phage content. 
Further work with the virustat was resumed 
with the 4x174 system, which gives clearer ly- 
sates and a lower fraction of resistant host cells. 
Immediate results were obtained with ten-Cell 
and larger chambers. Figure 2 shows run 43, and 
Fig. 3-5 show 47. The following were the primary 
observations of interest. 
(i) Continuous production of virus over at  l e s t  
several days is possible. Titers of 4x174 ran from 
101° to upwards of lW1/ml, a substantial fraction 
of the (also variable) batch yield, and to a rela- 
tively higher maximum fraction than with MS-2 
in the virustat, at least as far as here observed. 
(ii) After about 1 day, the initially clear lysates 
turned cloudy, and the foaming in the later Cells 
diminished to irnperceptibility, although substan- 
tial production, usually 10'0 or more, proved to 
be still continuing. Content of resistant mutants 
in the bacterial growth tube and in the output of 
the virus growth chamber during run 411, with 
a 20-Cell chamber, is shown in Fig. 6 .  Growth of 
resistant mutant content in both is apparent; the 
FIG. 6.  Growth of resistant mutants in virustat bac- 
terial growth tube and virus growth chamber output, 
during run 41 I .  
a Data on the flow rate, growth tube volume, 
and cell count are generally averaged over the 
fluctuations of the run. 10 Cells; average volume, 
10 ml each (except for M1 and M2, with 11 Cells, 
the 11th having 10 ml in M1 and 20 ml in M2). 
20 Cells; average volume, 5.2 ml, except for 
run (average volume, 7.5 ml). 
25 Cells; average volume, 5.2 ml. 
Run is not self-inoculating. 
ml, hr ml 
35 50 
20 / 55 
1 
2 .5  ' 3 
2 
4 l E 3 5 0  
2 40-50 
2 .5  90-150 
3 1 - 
3.6  1 13 
3 200-600 
4 1 16-23 
3 i 15-22 
5 .5  , 3 0 0  
4 . 5  70 
3 1 2d 
0 . 6  I 9d(?) 
3 . 2  14-90 
44 
50 
50 
54 
50 
52 
52 
20 
52 
170 
142 
54 
67 
70 
75 
84 
120 
170 
120 
105 
100 
128 
200 
170 
85 
10-30 
20-40 
3-10 
2-4 
10-20 
0.7-1.7 
1-2.5 
1 
0 .3-0 .7  
2.5-4 
3 
10 
12 
2-6 
1-3 
, hr 
64 
20 
24 
45 
40 
96 
74 
46 
73 
93 
45 
25 
125 
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content of the output stream rose to 10B/ml 
within 3 days of the run, and stayed there. (The 
irregularity in count is probably experimental 
variance.) Virus titer in the output following this 
nevertheless remained at 1010 to 2 x 1010, even at 
the highest levels of contamination with mutants, 
for the duration of the 6-day experiment. An 
interesting approximately exponential growth of 
mutants was noted in the bacterial growth tube. 
Changing of the bacterial growth tube on the fifth 
day for one with a culture containing many fewer 
mutants (dotted line in Fig. 6) did not appreciably 
decrease the high mutant concentration in the 
production of lysate. 
(iii) Sampling along the virus growth chamber 
was generally done at the first and last Cells, and 
generally every fifth Cell in between. A mono- 
tonic increase in virus content was generally ob- 
served, except at slow flow rates in which some 
drop could be noted toward the end of the path. 
A careful monitoring of the "titer profile" of a 
25-Cell virus growth chamber at three different 
flow rates in run ~$9 is shown in Fig. 7. Salient 
features are the increases with Cell numbers at 
high flow rates, a maximum at the slow rate, and 
the sharp decrease in titer in the first Cell as the 
flow rate increased. 
(iv) Self-inoculation proved more prominent 
than expected. All runs made in the 10-Cell cham- 
ber showed self-inoculation (and also the slower 
runs with 20 to 25 Cells), which required flow 
rates of at least 120 to 150 ml/hr to abolish the 
process. The criterion for loss of self-inoculation 
was rapid fall in virus titer in the first Cell on 
0 170 cclhr 
+ 5 2  cclhr 
0 20 cclhr 
Cal l  number 
FIG. 7 .  Virus "titer profle" along Cells of the virus 
growth chamber in the virustat, for variow flow rates, 
during run $9. 
cutting off the external inoculum stream; for 
presence of the process, the criterion was main- 
tenance of the same virus titers on cutoff of 
inoculum. 
(v) Clogging of tubes with lysis debris was a 
problem complicating the longer runs. A certain 
amount of stringy substance (obviously contain- 
ing proteins and nucleic acids, judging from some 
browning and partial iusolubility in strong HNOJ 
eventually appeared in all of the Cells, particu- 
larly the later ones. 
While the workability of the virustat might be 
considered inevitable, once its design is examined, 
many interesting problems and possibilities ap- 
peared during its planning and reduction to an 
operating device. Originally conceived and still of 
primary interest as a research tool to aid in 
mutagen studies in prospect and in progress, it 
was early clear that interest might also attend its 
use as a means for continuous production of 
viruses. No truly continuous methods of virus 
production have been published to our knowl- 
edge, and the principles of the virustat represent 
an original set of methods for accomplishing this. 
The following aspects of the design and operation 
of the virustat merit some detailed comment. 
Host cell production. As pointed out above, 
continuous virus culture requires radically dif- 
ferent, and more complex, apparatus from that 
of the well-established continuous pure-culture of 
complete microorganisms. Nor can viruses be 
merely cultured similarly to products of the 
microorganisms (e.g., penicillin, colicin), since 
they must by definition destroy, at least even- 
tually, their host cells. (We exclude lysogenic 
viruses from this statement.) A separate host-cell 
culture, continuously operating, is thus the first 
requisite of our system. 
For both bacterial hosts, E. coli strains C and 
3000, the medium flow rates required to keep the 
steady-state concentration of bacteria in the 
shoulder-of-the-growth-curve region, i.e., 2 X 108 
to 5 x 108/ml, were between 0.5 and 0.8 V per 
hour, V being the growth tube volume. The re- 
sultant corresponding average turnover times 
(i.e., lifetime during which each cell can multiply) 
of 2.0 to 1.25 hr thus lead to bacterial concentra- 
tions corresponding to current practice in batch 
lysates. At these concentrations, the doubling 
time has increased from the minimum, log-phase, 
time of about 40 min (in these media) to a figure 
25 to 100% larger, owing to the approach to satu- 
ration. With constant inflow and efflux, rather 
than a single total turnover, it is easy to show 
that the effective time for multiplication is the 
system time, i.e., the doubling time divided by 
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logd. When this time equals the turnover time, 
the count in the tube remains at equilibrium. 
Thus, a 40-min doubling time corresponds to a 
system time of close to 1 hr, which, if increased 
by 25 to loo%, will give the system time equal to 
the turnover times used. 
For sheer production purposes, the highest 
lysable concentration of host cells is desirable, 
both because of linear improvement in yield and 
because of an occasional supralinear increase due 
to lysis-inhibition effects. For experiments at 
much lower host-cell concentrations, however 
(e.g. those in which bacteria in strict log phase 
are needed), the present system for generating 
host cells would not have worked. At strict log 
phase, the maintenance of host-cell concentration 
at a constant level would require precise delivery 
of enough medium to dilute out the bacteria as 
fast as they grow; i.e., the turnover time would 
equal the log-phase system time. Slight variations 
in the turnover time, or in the system time con- 
stant, due to changes in flow rate or temperature, 
would cause change in the equality, after which 
the cell concentration would change over a wide 
range. Either the concentration would run down 
to zero, if the turnover time were less than the sys- 
tem time, or, if the opposite held, the concentra- 
tion would run up to the nonlinear part of the 
growth curve. Thus, control of the output cell 
concentration, easily held within rather narrow 
limits under the near-saturation conditions of our 
experiment by the slowing-down of bacterial 
multiplication as the cell concentration increases 
and vice versa, would be highly erratic at the 
lower cell concentrations of the log-phase area. 
At such concentrations, a servomechanism, e.g., 
the "breeder" of Fox and Szilard (3), would be 
necessary to maintain accurate constancy of out- 
put, raising and lowering medium input rate as 
the host cell concentration went up or down. 
For virus production and many research pur- 
poses, the chemostat (lo), relying as it does on a 
nutrient-limited state of near-saturation, is un- 
suitable. The limiting nutrient may slow up virus 
production, or the bacteria may be rather less 
susceptible to successful virus infection. More- 
over, the rate of output for a given volume of cul- 
ture medium is slowed down substantially when 
close to saturation, thereby requiring a larger 
apparatus for a given amount of desired cell 
product. 
Virus chamber Cells. The heart of the virustat 
method, of course, lies in the multi-Cell virus 
growth chamber. Although one can imagine d e  
vices which carry the inoculated cells continu- 
ously through their life cycle, rather than through 
the set of stirred discrete Cells comprising the 
virustat chamber, use of these would multiply the 
problems of stirring, aeration, and surface ac- 
cumulations of mutants and debris. On the experi- 
mental scale used in our work, a continuous 
chamber would have been well-nigh impossible; 
on a larger scale, such would offer no advantage 
over the multi-Cell chamber. Decision as to the 
number and design of the Cells, however, rests 
with the system requirements. A cell-virus system 
has a cycle complexity, with need for "harvesting" 
at the right time. Hence, batch methods, properly 
used for organisms with any morphologically 
distinct life stages, have also been the methods of 
choice for viruses (and for replicating factor, tails, 
early enzymes, etc). The narrowing of the har- 
vesting times is the major factor dictating the 
optimal number of Cells and the permissible 
distribution of "ages" in the product. For a cell- 
lysing system, the product "age" must exceed the 
lysis time for a period sufficient to allow the large 
majority of all infected cells to have spent at least 
this amount of time in the chamber. Nor can this 
time be extended too long without both decreas- 
ing the production capabilities of the apparatus 
and allowing some fraction of the possibly labile 
virus to adsorb onto debris or otherwise be in- 
activated before emerging. 
The use of a number of Cells can be seen to 
reduce the spread in average "ages" of emerging 
cells in the product, simply by an intuitive statisti- 
cal argument that a cell from a population spend- 
ing variable time in many Cells will have less 
variability of average total time than will one 
from a population spending the same average 
total time, but doing so in only one or a few Cells. 
For any single Cell, assuming good mixing, the 
incremental "age" distribution between input 
and output is a simple exponential, with decay 
constant (base e) equalling the reciprocal of the 
average turnover time of the Cell. Expressing 
"age" in units of this turnover time leads to the 
dimensionless variable T, defined equal to rt/Vo, 
where r is the flow rate in milliliters per second, 
Vo the Cell volume, and t the actual "age" in 
seconds. T, simplifying the resulting distributions, 
may be regarded as the average "age," expressed 
as number of Cells worth of turnover. Use of the 
"age" variable T reduces the distribution function 
in the first cell simply to W(T) = eT. 
For the second and subsequent (labeled nth) 
Cells, it can readily be shown (9) that the "age" 
distribution for the population in the Cells (al- 
ways assuming rapid and complete intra-Cell 
mixing) is, simply : 
W(n, T) is recognized as the Poisson distribution 
function Pn-l(T), with T the "age" variable, a 
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continuous argument, and n, the number of Cells, 
a discrete index number, taking on values from 1 
through N. W(n, T) is, of course, normalized to 
unity when integrated over all T for any value 
of n. It is also normalized to unity for a summa- 
tion over all n - 1, from 0 to infinity, with a fixed 
value of T. 
The second, spatial, normalization has impor- 
tant consequences. It means that the cells with a 
particular "age" T are distributed among the 
various Cells in the manner given by equation 1, 
the fractions summed over all possible Cells 
totalling unity. If any terms in this summation 
have non-negligible value for values of n larger 
than N, the total number of Cells, such cells 
would be in hypothetical Cells numbered N + 1 
and higher. Physically, this means the fractions 
would be in the product emerging from the virus 
growth chamber. This distribution, giving, as it 
does, the positions of the cells of one particular 
"age," can now be used to establish the distribu- 
tions of location at  which an event occurring at  a 
fixed time, such as (to a first approximation) 
lysis, takes place. If we define the dimensionless 
TI equal to rtl/Vo, where tl is the physical lysis 
time, and ask where the cell is at this "age," i.e., 
at lysis, equation 1 with TI substituted for T gives 
an answer for the N Cells of the chamber and for 
the infinity of succeeding Cells representing the 
production stream. 
In general, the summation 
gives the fraction of the cells which still find them- 
selves in the growth chamber Cells when their 
"age" equals TI. This is, of course, the lysed frac- 
tion, and the unlysed fraction is the summation 
on the left in equation 2 subtracted from unity, 
recognizable as the summed Poisson distribution 
with continuous argument TI and discrete index 
number N, generally written as P,(N, TI). 
Parenthetically, equation 2 can also be derived 
by the more physically appealing approach of 
integrating equation 1 over T from Tl to m to get 
the fraction of cells in the Nth Cell which are 
older than TI, i.e., lysed. The summed distribution 
(equation 2) appears as a result of the iterated 
integration by parts of P,-l(T). 
From the properties of Pn(N, Tl), we can now 
closely predict the performance of a chamber 
with known N, Cell volume, flow rate, and con- 
taining a host-virus system with a known lysis 
time. Computing TI and substituting in equation 2 
gives the lysed fraction of cells in the product. 
Table 2 illustrates the efficiency of several multi- 
plicities (N) of chambers in carrying most of the 
infected cells through to "ages" of at least Tl . 
TI should not exceed N, or the cell will spend an 
average total time in the chamber less than its 
actual lysis time, and the majority of cells will not 
be lysed on emergence. This can be seen from the 
fact that the average total time equals NVo/r, 
while the actual lysis time equals TiVdr, from 
the definition of Tl , and the fact that the average 
total time equals N times the turnover time of 
Vo/r. For values of N equal to 1, 10, and 20, and 
of Tl equalling 0.5, 0.8, 0.9, and 1.0 N, we read 
thelysed fractionof product from Table 2. Table 2 
also presents the necessary value of TI for those 
sizes of chamber which give 99% lysis. 
For a single-Cell chamber, the calculations are 
very simple, and can be made from either equa- 
tion l or 2. If the average time in the Cell equals 
the lysis time tl , then TI = 1, and only l/e, or 
36.8%, of the cells lyse before emerging, a poor 
performance. Setting TI = 0.5 N, or 0.5, is ac- 
complished by halving the flow rate. One might 
expect a striking increase in the lysed fraction, 
but it only rises to 60.6%. In fact, to assure 995, 
lysis, it is necessary to slow down the flow rate 
100-fold, to a TI of 0.01. This simply reflects the 
substantial number of fresh cells which can wash 
out of a single Cell chamber, unless the rate is 
made impractically slow. On the other hand, for 
a 10-Cell chamber, when the rate is slowed down 
to half of the (average time = lysis time) figure, 
only 3.2% of the cells are unlysed; for a 20-Cell 
chamber, only 0.02% of the cells escape lysis 
under these conditions. For production pur- 
poses, the value of a very minute unlysed fraction 
is small, and a 20-Cell chamber would simply be 
run somewhat faster, say at TI = 0.7 to 0.8 N, or 
at average total times of 1.2 to 1.3 times lysis 
time. 
For lysis which does not occur with absolute 
synchrony, the above calculations are in error on 
the optimistic side. Spread in actual lysis times 
will increase unlysed fraction at any flow rate, 
although in many cases by imperceptibly small 
amounts. In general, such asynchrony will limit 
TABLE 2. Lysed fraction of the product wirlt  an 
n-Cell chamber and various T val~tes 
Value of S 
1 10 ' 20 - 
Values of TI  for 99% lysis: N = 1, 0.01 N; N = 
10, 0.42 N; N = 20, 0.56 N. 
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the wisdom of using more Cells than necessary to 
get an "age" distribution with the same order of 
narrowness of time spread as that of the lysis 
times. 
The number of Cells in the chamber is thus seen 
as a quantity whose increase gives better uni- 
formity of "age" of product. Economics militates 
against the encumbrance of too many Cells; 
indeed, little advantage accrues when the "age" 
peaking is sharper than the natural peaking of 
lysis time. The Cell minimum number is dictated 
by the desirability of a culture which is nearly 
completely lysed, the natural loss of titer in an 
overaged culture, and the decrease in production 
when the flow is slowed up (and by factors dis- 
cussed below, namely, self-inoculation and sweep- 
out of resistant mutants). For large-scale produc- 
tion, we would estimate that something like ten 
Cells would prove optimal, with a self-inoculating 
system. 
Self-inoculation. This phenomenon, a semi- 
expected one, appeared in the first run (MI of 
Table 1) with the breakdown of an inoculum 
pump shortly after the start of the run. On the 
assumption that sufficient infected cells could sur- 
vive in the first Cell so that the burst of virus 
produced would at least replace the inoculum 
swept out by the flow of medium, the experiment 
was continued without external inoculation. Pro- 
duction of virus continued for several days with- 
out external inoculation, indicating that self- 
inoculation as described was indeed occurring. 
Especially noteworthy as a criterion of self- 
inoculation is the titer in the first Cell. If no self- 
inoculation is taking place, this will drop precipi- 
tously with interruption of external inoculum; if 
external inoculum is present, the first Cell titer 
will equal that of the inoculum times the flow 
ratio of inoculum to host cell streams. Substan- 
tially higher titer, with or without inoculum flow, 
shows self-inoculation building up to levels of 
multiplicity of infection which depend on the flow 
rate. 
One can, however, easily predict fulfilment of 
the critical condition for self-inoculation. Over 
the dimensionless time TL,  the fraction of cells 
remaining in the first Cell will be, by equation 1, 
simply e-Ti. This unwashed-out fraction applies 
also to any cell type present, in particular to in- 
fected cells. If the average burst sue is B (a rea- 
sonable distribution of burst sizes will affect mat- 
ters but slightly), then R = defines a multi- 
plication constant giving the fraction of the 
inoculum remaining in the first Cell after washout 
for time TI and subsequent bursting of the frac- 
tion remaining. Values of R below unity can be 
seen to allow washout of inoculum, if not sup- 
plied; at the critical value of unity or higher, virus 
derived from bursting of infected cells in the first 
Cell will replace inoculum as fast or faster than 
it can be washed out. If R is less than 1, the inocu- 
lum multiplies in this cell by the overall factor 
x? Ri = 1/1 - R (i = 0) prior to washout. At 
R = 1, the inoculum is exactly replaced as fast as 
it washes out; at R > 1, the titer in the first cell 
grows larger even without added inoculum. The 
increase of titer is, however, self-limiting. The 
effective value of B, i.e., the number of released 
virus per adsorbed virus, must decrease as the 
multiplicity of infection, which we designate m, 
increases. Assuming a constant burst size inde- 
pendent of m, and complete absorption within 
the first Cell, B will be decreased by the factor 
(1 - eem)/m, a number approaching l/m at high 
m, and unity at low m. This decrease in the effec- 
tive value of B will limit the value of R to unity, 
when steady-state conditions have been estab- 
lished: R = 1 = Bo[(l - e")!m]e-Tl (Bo being 
B at low m). For values of rn hlgher than four or 
five, it is,accurate to write: 1 = [B$m]e-Ti, 
hence, 
From the burst size and multiplicity of infection, 
if known, one could thus calculate Tl , and, from 
this and the turnover time, the true (average) 
lysis time prevailing in the system, t~ . As here 
calculated, and as generally observed, tl includes 
the adsorption time. 
The first two MS-2 runs show this dependence 
of self-inoculation on the flow rate (which alters 
TI ,  and thereby rn and R) strongly. The observed 
ratios of virus to bacteria in the first Cell were 1.5 
and 50, respectively, the difference being due to 
the two flow rates giving 18- and 30-min turnover 
times (Volt-) in the first Cell, respectively. Assum- 
ing that the first run was just beyond the border- 
line of self-inoculation (a condition certainly not 
far from the truth), and assuming also a burst 
size of 104 (also close to the truth and not criti- 
cal), we can calculate the average lysis time in this 
Cell to be 18 In (lo4) = 166 min, a figure in line 
with visual experience with this virus strain. By 
use of this lysis time with the turnover rate in the 
second run, in one lysis time there should be 
166/30 = 5.5 turnovers in the Cell. The overall 
multiplication of virus here would then be ex- 
pected to give lo4 x e-5,6 = 40, a figure in agree- 
ment with the observed first-Cell virus-bacteria 
ratio of 50. 
Similar calculations with the 4X 174 runs sug- 
gest an average lysis time of 25 to 30 rnin, a range 
somewhat lower than that visually observed. Un- 
certainty of burst size and the threshold of self- 
inoculation, and complex weighting of both burst 
size and lysis time, however, dong with some 
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possible effects of washout (see below), have made 
this calculation uncertain. 
Figure 7 shows, among other things, the effect 
of flow rate on self-inoculation. At the two slower 
rates, the first Cell showed high titers indicative 
of self-inoculation; moreover, the inoculum flow 
could be discontinued without appreciable change 
in virus titer in the first Cell or in the production. 
At 170 ml/hr, however, inflow of inoculum was 
necessary, and the first-Cell virus content was ap- 
proximately twice that calculated from inoculum 
flow, indicating a value of R of about 0.5. A faster 
rate would decrease R rather precipitously, but 
would also result in incomplete lysis in the prod- 
uct, unless more Cells than the 25 present were 
used, as one can extrapolate from inspection of 
the curves of Fig. 7. 
For simple production purposes, self-inocula- 
tion is a great convenience, as it eliminates ne- 
cessity for a portion of the system. Run thus, the 
virustat, once set up and inoculated, has a single 
(medium) liquid inflow, and a single (lysate) 
liquid outflow. For certain purposes, however, 
running in a non-self-inoculating condition is de- 
sirable. Under such conditions, a relatively large 
number of Cells in the chamber is necessary. All 
runs with 10 Cells giving reasonably clear lysate 
required slow enough flow rate to self-inoculate. 
Even with 20 to 25 Cells, some part of the virus 
produced was generated within the first Cell, at 
fairly high flow rates. 
Inoculation, made in these runs where neces- 
sary with prepared filtered lysate (sometimes di- 
luted to control the m), can also be accomplished 
by recycling a small fraction of the product into 
the svstem. For control of resistant host mutants. 
this &quires filtration, centrifugation, or possibl; 
temporary bactericidal treatment of the recycled 
product. 
Mutants and the washout process. A problem 
considered early in the design of the virustat was 
that of formation of resistant host-cell mutants. 
A spontaneous mutant rate, generally small, puts 
new mutants into the system each time the bac- 
teria double. In the presence of the virus inocu- 
lum, such mutants can multiply. For a self- 
inoculating system, or one whose inoculum is 
rendered free of bacteria, this multiplication is at 
first glance seen as unimportant. In the slowest 
runs considered, the host bacteria spend no more 
than a half-dozen generations in the virus growth 
chamber, and cannot therefore multiply more 
than 100-fold or so (even if not destroyed by 
virus) without being washed out of the chamber 
by the flow of medium. In the faster, non-self- 
inoculating runs, the multiplication of resistant 
cells in the chamber is only about fourfold. Thus, 
use of a culture with less than 1 0 - 3  or so resistant 
organisms should result in the overwhelmingly 
largest portion of the cells lysing. Expectation 
with the E. coli C culture is for a mutation rate 
to +X17Cresistant forms of the order of per 
generation. The experience of Szilard and Noeck 
(10) with the chemostat bears out the postulate 
of a linear increase in mutants with time. The 
number of generations required to  reach a mu- 
tant level of 10-3, about 1,000, would require 
several weeks of growth in the bacterial growth 
tube. Experience with the virustat, however, 
showed visible clouding of the originally clear 
production within 1 day, and complete loss 
of normal lysate appearance within 2 days, al- 
though production still continued for substan- 
tially longer periods. The results cited for run 
411 (Fig. 6) show that the picture is more un- 
favorable than that predicted from idealized con- 
siderations, both in the bacterial growth tube and 
in the virus growth chamber. The remarkable 
slow exponential increase of resistant mutants in 
the bacterial growth tube, in the certain absence 
of any virus challenge (which would forthwith 
terminate the run), means that the mutants must 
have some slight and unpredictable a priori 
growth advantage, even in the absence of virus. 
Recent reports (4,8) suggest that, with complex 
media not relying on a single growth-limiting 
nutrient, a continuous bacterial culture may show 
a better-than-constant rate of emergence of auxo- 
trophic mutants. Its applicability here is not 
certain, but such effects in the growth tube may 
also account for the unexpected rise in the 
mutant population. 
Replacing the growth tube is a way of cutting 
down the number of mutants entering the virus 
growth chamber; the last 2 days of the run show 
the (new) growth tube with relatively few, but in- 
creasing, mutants. The curve giving the resistant 
concentration in the production, however, shows 
that resistant mutants, at least under conditions 
prevailing in the virustat, arise primarily in the 
virus growth chamber, and not in the bacterial 
growth tube. If the latter were the case, the resist- 
ant concentration in the production would be ex- 
pected to run reasonably close to, and not more 
than fourfold larger than, the lower line. This is 
clearly not the case, except conceivably at the 
outset. The rise of resistant mutants is faster in 
the virus growth chamber, and when they have 
reached the surprising level of about 10s/ml, even 
replacement of the growth tube and depression 
of mutant invut bv a factor of at least 108 has no 
significant effect on reducing their output con- 
centration. We have therefore reluctantly con- 
cluded that there is some source of resistant 
mutants of unexpectedly high degree within the 
virus growth chamber. This source must reflect a 
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partial failure of washout and some growth of 
resistant bacteria in slow-moving "pockets," or 
on inner surfaces of the apparatus. It is likely that 
technical improvements in this situation can be 
made. Coating the walls of the chamber with sili- 
cone should reduce the tendency of bacteria to 
grow on the walls; reasonable amounts of a com- 
patible detergent will keep some bacteria from 
clumping and standing still. Simple increase in 
the size of the apparatus, i.e., increasing the 
volume-surface ratio, will decrease such effects. 
Above all, stagnant pockets, such as those which 
can form at sampling tees and glass-rubber tubing 
junctions, should be avoided. Although we are as 
yet not reporting on solutions to these problems, 
some preliminary observations with combinations 
of nonionic detergents and antifoams have indi- 
cated that it is quite possible to culture bacteria 
to the point of lysis with relatively low foaming, 
and with improvement in the washout of resistant 
mutants, especially from siliconized glass sur- 
faces, if used in the virustat. 
A further limitation, related to washout, is the 
debris accumulation observed. This, too, may be 
ameliorated if the medium has sufficient detergent 
properties (and the vessel ,walls nonadhesive ones) 
to carry most of it off. It must be recognized that 
any substantial amount of adherent debris will by 
itself create conditions in which flow rates are ex- 
tremely slow at some portion of the chamber 
surfaces, which thereby furnish shelter for culture 
of mutants. The debris formed is directly propor- 
tional to the total number of cells lysed. Lower 
host cell concentrations will give longer debris- 
free runs. For production purposes, this is not 
much help, but, in certain experimental situations 
where running at low bacteria concentrations can 
give the desired data, such would indeed lengthen 
the useful life of the experiment. 
Continuous production of pure virus. For most 
virus applications, purification is desirable. One 
of the most appealing possibilities for use of the 
virustat in production is as a supplier of raw 
lysate to some continuous purification process. 
Processing involving ordinary centrifugation, 
liquid-liquid partitioning, treatment with reagents 
or absorbents, and some two-dimensional separa- 
tions (e.g., curtain electrophoresis) are readily 
adapted to continuous operation. Operations on 
solid residues, including collection and dispersion 
sediments and pellets and filtration, settling, or 
centrifugation with processing of the solids, are 
d s c u l t  to make continuous, as is simple column 
or supporting medium separation of any sort, 
which generally needs a batch charge. Thus, the 
usual techniques lead to pellet collection and re- 
dispersion, or columnlike separation, and cannot 
be directly used in a method with a continuous 
lysis inflow. Large initial reductions of handling 
of volumes into pellets, or slurries of high virus 
content, however, are quite feasible addenda to 
the virustat. For instance, the two-phase separa- 
tion of virus at the liquid-liquid interface can 
take a raw lysate input, add and mix streams of 
the soluble but incompatible polymers (e.g., 
Dextran and Carbowax), pass into an ordinary 
continuous centrifuge, drawing off clear top and 
bottom fractions, and building up the interface 
yield. Some servomechanism would be needed to 
prevent the interface from leaving the inside of 
the centrifuge. When a maximal amount of ma- 
terial had accumulated in the interface, the con- 
tents could then be emptied in batch for further 
ordinary processing, with the remainder of the 
material requiring only small-scale mampulations. 
Alternatively, a continuous low-speed cycle of 
centrifugation, followed by a high-speed one, 
could give an increasing pellet containing virus- 
sized particles. The requirements of ultracentri- 
fuge-range velocities for putting virus into a 
density gradient band demands a special kind of 
equipment, now reaching availability in the com- 
mercial zonal ultracentrifuge. 
Completely continuous production-scale purifi- 
cation of virus would require some modification 
of present methods. Continuous production of an 
interface slurry, followed by a stage of curtain 
electrophoresis and a final continuous density- 
gradient in a zonal ultracentrifuge, could perhaps 
accomplish this in a satisfactory way. Virus- 
derived substances, including intracellular by- 
products of the viral attack, such as early en- 
zymes, replicating factor, partially complete 
~articles. or. with mammalian host cells, inter- 
feron, are a~continuously producible and &haps 
purifiable by running the infections in the 
virustat so as to produce viruses, or unlysed cells 
of the proper age, and subsequent treatment as 
the product requires. 
The raison dctre  of the virustat, like that of the 
chemostat and family (3, 7, lo), lies not only in 
its ability to manufacture virus efficiently, but 
also in its use as a research tool for population 
studies in virus-host systems, particularly ac- 
celerated mutation and evolution. It was origi- 
nally envisioned as a simpler solution to the 
problem of "exhaustive mutagenesis" (H. Jacob- 
son and L. M. Blatt, Meeting Abstr., 6th Intern. 
Congr. Biochem., 1964), i.e., complete attack on 
all possible nonlethal mutable sites by a specific 
mutagen. This would be incredibly laborious by 
any kind of batch method, but feasible with a few 
months of continuous treatment in the virustat. 
Sending the virus output into a mutagen treat- 
ment or selection chamber, or both, and recycling 
survivors (which would include. a large mutant 
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population, also possibly selected for resistance t o  of a patent application owned by the California Insti- 
a given set of conditions), accomplishes a con- tute Research Foundation. 
tinuous culture change far greater than that ob- 
tainable in any other way. For  instance, acid-re- 
sistant varieties of virus could be efficiently 
selected by acid treatment of the lysate, recycling 
the survivors of this challenge so  as  to  reinfect the 
host-cell stream. In  vitro mutagens can be used a t  
this point to  stimulate variability. In vivo muta- 
gens, of course, must be introduced into the virus 
growth Cells. 
For such purposes, the virustat should be run 
at  low host cell concentrations, t o  minimize 
clogging and to keep growth in strict log-phase. 
Moreover, to  receive the effect of the change in 
the species, the self-inoculation factor would have 
to be eliminated, or unchanged viruses would 
dilute out the changed ones. Thus, research runs 
will typically require upwards of 25 Cells and im- 
proved servo host-cell concentration controls. 
Samples withdrawn continuously during this 
procedure should show continuous, if slow, popu- 
lation alterations in host range, survival, and im- 
munological and, probably, chemical properties. 
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